oppn parties Shortcuts Will Not Work In Developing A Vaccine For Coronavirus

News Snippets

  • NCLT initiates bankruptcy proceedings against former Videocon chairman Venugopal Dhoot for defaulting on loans of Rs 6158cr as personal guarantor in two group companies
  • LIC approves 1:1 bonus share issue
  • Gold and silver futures also go down by 0.7% and 2.2% respectively
  • Stocks tumbled again on Monday as crude prices rose: Sensex went down by 703 points and Nifty by 207 points
  • Supreme Court refuses to cancel the land-for-jobs FIR against Lalu Prasad
  • The spectre of El Nino haunts India: IMD predicts 'below normal ' monsoon this year
  • Labour protest over increase in wages by 35% (as per Haryana example) turns violent in Noida, nearly 200 were detained by the police
  • Congress leader Sonia Gandhi said that the delimitation exercise must be carried out after the Census is complete
  • PM Modi says Parliament is on the verge of creating history as the Houses get ready to take up the women's reservation bills
  • Tata Sons chairman N Chandrasekaran said that TCS COO Aarthi Subramanian is conducting a thorough inquiry to establish facts and identify individuals involved in the sexual harassment allegations at the company's Nashik office
  • Asha Bhonsle laid to rest with full state honours on Monday in Mumbai
  • AAP leader Arvind Kejriwal once again approached the Delhi HC to request the recusal of a judge from his case
  • Candidates Chess: R Vaishali on the verge of creating history, but needs two wins - one with black pieces - against formidable opponents to emerge as the challenger
  • Rohit Sharma, who retired hurt in the match versus RCB, underwent scans for possible hamstring injury
  • IPL: Abhishek Sharma fails for SRH but Ishan Kishan (91) shines. Then, Vaibhav Sooryavanshi fails for RR and SRH bolwers, especially unheralded Praful Hinge (4 for 24) and Sakib Hussain (4 for 24) win it for SRH. This was the first loss for table-toppers RR
Supreme Court questions Election Commission about SIR SOP and why logical discrepancy was introduced only in Bengal
oppn parties
Shortcuts Will Not Work In Developing A Vaccine For Coronavirus

By Sunil Garodia
First publised on 2020-07-06 18:09:56

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator. Author of Cyber Scams in India, Digital Arrest, The Money Trap and The Human Hack

Vaccines are used to prevent infections. Hence, their effectiveness has to be scientifically proven as per admissible norms before they are launched in the market for the use of the general public. However strong and urgent be the health scare for which the vaccine is being developed, the due process cannot be bypassed to launch a product that has not been stringently tested and approved for its efficacy in preventing the infection.

Hence, the ICMR directive to Bharat Biotech to "speed-up" clinical trials of the vaccine, that they are jointly developing as a "top priority project", so that it can be launched within August 15 must be condemned. Clinical trials cannot be sped up. There are thousands of things involved and continuous feedbacks and monitoring of patients administered with the vaccine during such trials take time. In any case, no vaccine or drug can be safely launched before successful clinical trials on a given set of individuals (a small number in Phase 1 and then a much larger number in Phase 2) over a given period of time. The results, such as the development of antibodies in the recipients, are closely monitored by scientists. It is not a process that submits itself to pre-set deadlines. Even the identification, selection and getting volunteers are time consuming processes.

The bureaucracy in India must not try to undermine scientific norms just to please their political masters. In fact, since they are supposed to be subject-experts (as Dr. Balram Bhargava, director-general of ICMR is), they must make the political leadership aware of the pitfalls involved in rushing things. There is no doubt that a vaccine, when developed, would be a huge relief to the entire humanity. But if due process is not followed and a dud vaccine is launched, India will become the laughing stock of the world. Hence, instead of setting deadlines, ICMR should insist on getting things done in the most scientific way following all global norms. Shortcuts will be self-defeating.